Home LiteratureArticle Details
PMID: 11238872 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.

Journal of virology ·Vol. 75 ·No. 7 ·2001-04-00 ·Pages 3462-8

Shioda T, Nakayama EE, Tanaka Y, Xin X, Liu H, Kawana-Tachikawa A, Kato A, Sakai Y, Nagai Y, Iwamoto A

Abstract

CCR5 is an essential coreceptor for the cellular entry of R5 strains of human immunodeficiency virus type 1 (HIV-1). CCR5-893(-) is a single-nucleotide deletion mutation which is observed exclusively in Asians (M. A. Ansari-Lari, et al., Nat. Genet. 16:221-222, 1997). This mutant gene produces a CCR5 which lacks the entire C-terminal cytoplasmic tail. To assess the effect of CCR5-893(-) on HIV-1 infection, we generated a recombinant Sendai virus expressing the mutant CCR5 and compared its HIV-1 coreceptor activity with that of wild-type CCR5. Although the mutant CCR5 has intact extracellular domains, its coreceptor activity was much less than that of wild-type CCR5. Flow cytometric analyses and confocal microscopic observation of cells expressing the mutant CCR5 revealed that surface CCR5 levels were greatly reduced in these cells, while cytoplasmic CCR5 levels of the mutant CCR5 were comparable to that of the wild type. Peripheral blood CD4(+) T cells obtained from individuals heterozygous for this allele expressed very low levels of CCR5. These data suggest that the CCR5-893(-) mutation affects intracellular transport of CCR5 and raise the possibility that this mutation also affects HIV-1 transmission and disease progression.

MeSH Terms
Amino Acid Sequence Biological Transport Cytoplasm/metabolism HIV-1/physiology HeLa Cells Humans Jurkat Cells Mutation Receptors, CCR2 Receptors, CCR5/chemistry,genetics,metabolism Receptors, Chemokine/chemistry
Chemicals
CCR2 protein, human Receptors, CCR2 Receptors, CCR5 Receptors, Chemokine
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Shioda T
Research Institute for Microbial Diseases, Osaka University, Osaka, Tokyo, Japan. shioda@biken.osaka-u.ac.jp
Nakayama E E
Tanaka Y
Xin X
Liu H
Kawana-Tachikawa A
Kato A
Sakai Y
Nagai Y
Iwamoto A
References (58)
58 references, click to expand
  1. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Nat Med. 1998 Mar;4(3):350-3 PMID: 9500612
  2. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
    Cell Immunol. 1998 Nov 1;189(2):160-8 PMID: 9790730
  3. Dissociation of ligand-induced internalization of CXCR-4 from its co-receptor activity for HIV-1 Env-mediated membrane fusion.
    Arch Virol. 1998;143(5):851-61 PMID: 9645193
  4. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.
    AIDS. 1998 Jun 18;12(9):F85-90 PMID: 9662191
  5. Use of chemokine receptors by poxviruses.
    Science. 1999 Dec 3;286(5446):1968-71 PMID: 10583963
  6. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.
    J Neuroimmunol. 2000 Jan 3;102(1):98-106 PMID: 10626673
  7. Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus.
    AIDS Res Hum Retroviruses. 2000 Jan 1;16(1):27-35 PMID: 10628814
  8. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.
    J Infect Dis. 2000 Mar;181(3):927-32 PMID: 10720514
  9. Novel variant of the CCR5 gene in a Vietnamese population.
    Microbes Infect. 1999 Feb;1(2):123-4 PMID: 10917742
  10. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
    Lancet. 1986 Sep 20;2(8508):660-2 PMID: 2429124
  11. Biologic features of HIV-1 that correlate with virulence in the host.
    Science. 1988 Apr 1;240(4848):80-2 PMID: 2832945
  12. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
    Lancet. 1989 May 6;1(8645):983-5 PMID: 2565516
  13. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.
    Virology. 1990 Mar;175(1):139-48 PMID: 1689917
  14. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.
    J Virol. 1993 Apr;67(4):1772-7 PMID: 8095306
  15. Genotypic and phenotypic characterization of HIV-1 patients with primary infection.
    Science. 1993 Aug 27;261(5125):1179-81 PMID: 8356453
  16. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.
    Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2752-6 PMID: 8146186
  17. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    J Virol. 1994 Sep;68(9):5411-22 PMID: 8057423
  18. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.
    Science. 1995 Dec 15;270(5243):1811-5 PMID: 8525373
  19. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  20. Identification of a major co-receptor for primary isolates of HIV-1.
    Nature. 1996 Jun 20;381(6584):661-6 PMID: 8649511
  21. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
    Nature. 1996 Jun 20;381(6584):667-73 PMID: 8649512
  22. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.
    Cell. 1996 Jun 28;85(7):1135-48 PMID: 8674119
  23. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.
    Cell. 1996 Jun 28;85(7):1149-58 PMID: 8674120
  24. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Science. 1996 Jun 28;272(5270):1955-8 PMID: 8658171
  25. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
    Cell. 1996 Aug 9;86(3):367-77 PMID: 8756719
  26. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
    Nature. 1996 Aug 22;382(6593):722-5 PMID: 8751444
  27. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
    Nature. 1996 Aug 29;382(6594):829-33 PMID: 8752280
  28. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
    Nature. 1996 Aug 29;382(6594):833-5 PMID: 8752281
  29. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
    Science. 1996 Sep 27;273(5283):1856-62 PMID: 8791590
  30. HIV blocked by chemokine antagonist.
    Nature. 1996 Oct 3;383(6599):400 PMID: 8837769
  31. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking.
    J Biol Chem. 1997 Jan 10;272(2):1038-45 PMID: 8995400
  32. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense.
    Genes Cells. 1996 Jun;1(6):569-79 PMID: 9078386
  33. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity.
    Proc Natl Acad Sci U S A. 1997 May 13;94(10):5061-6 PMID: 9144190
  34. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
    J Exp Med. 1997 May 5;185(9):1681-91 PMID: 9151905
  35. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry.
    Science. 1997 Jun 20;276(5320):1874-8 PMID: 9188536
  36. The extent of genetic variation in the CCR5 gene.
    Nat Genet. 1997 Jul;16(3):221-2 PMID: 9207783
  37. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Science. 1997 Aug 15;277(5328):959-65 PMID: 9252328
  38. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
    Virology. 1997 Aug 4;234(2):340-8 PMID: 9268166
  39. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
    Nat Med. 1997 Oct;3(10):1160-2 PMID: 9334732
  40. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus.
    J Gen Virol. 1997 Nov;78 ( Pt 11):2813-20 PMID: 9367367
  41. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32.
    J Biol Chem. 1997 Dec 5;272(49):30603-6 PMID: 9388191
  42. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)
    Science. 1998 Jan 16;279(5349):389-93 PMID: 9430590
  43. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.
    Lancet. 1998 Jan 3;351(9095):14-8 PMID: 9433423
  44. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Science. 1998 Dec 4;282(5395):1907-11 PMID: 9836644
  45. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus.
    J Exp Med. 1998 Dec 7;188(11):2057-65 PMID: 9841919
  46. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4581-5 PMID: 10200305
  47. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function.
    J Biol Chem. 1999 Jun 4;274(23):16228-34 PMID: 10347178
  48. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6873-8 PMID: 10359806
  49. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blood. 1999 Sep 15;94(6):1899-905 PMID: 10477718
  50. Association of CCR5 delta32 with reduced risk of asthma.
    Lancet. 1999 Oct 9;354(9186):1264-5 PMID: 10520641
  51. A new classification for HIV-1.
    Nature. 1998 Jan 15;391(6664):240 PMID: 9440686
  52. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
    J Clin Invest. 1998 Feb 15;101(4):746-54 PMID: 9466968
  53. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication.
    J Biol Chem. 1998 Feb 20;273(8):4289-92 PMID: 9468473
  54. Novel alleles of the chemokine-receptor gene CCR5.
    Am J Hum Genet. 1997 Dec;61(6):1261-7 PMID: 9399903
  55. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.
    Nat Med. 1998 Jul;4(7):786-93 PMID: 9662369
  56. Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus.
    Curr Biol. 1998 Jul 30-Aug 13;8(16):943-6 PMID: 9707408
  57. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).
    Lancet. 1998 Sep 12;352(9131):866-70 PMID: 9742978
  58. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion.
    FEBS Lett. 1998 Apr 24;426(3):367-72 PMID: 9600268
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-04-00
Pages
3462-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114139
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com